{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T08:32:26Z","timestamp":1772613146238,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T00:00:00Z","timestamp":1430784000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s40256-015-0121-8","type":"journal-article","created":{"date-parts":[[2015,5,4]],"date-time":"2015-05-04T08:49:22Z","timestamp":1430729362000},"page":"289-293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Blood Urea Nitrogen\/Creatinine Ratio and Response to Tolvaptan in Patients with Decompensated Heart Failure: A Retrospective Analysis"],"prefix":"10.1007","volume":"15","author":[{"given":"Dai","family":"Okayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Shiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Minami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Tsuruoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhisa","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,5]]},"reference":[{"key":"121_CR1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2006.09.011","volume":"119","author":"M Gheorghiade","year":"2006","unstructured":"Gheorghiade M, Filippatos G, De Luca L, et al. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med. 2006;119:S3\u201310.","journal-title":"Am J Med"},{"key":"121_CR2","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/01.CIR.0000070422.41439.04","volume":"107","author":"M Gheorghiade","year":"2003","unstructured":"Gheorghiade M, Niazi I, Ouyang J, et al. Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial. Circulation. 2003;107:2690\u20136.","journal-title":"Circulation"},{"key":"121_CR3","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","volume":"297","author":"MA Konstam","year":"2007","unstructured":"Konstam MA, Gheorghiade M, Burnett JC Jr, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial. JAMA. 2007;297:1319\u201331.","journal-title":"JAMA."},{"issue":"Suppl 1","key":"121_CR4","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1007\/s10557-011-6303-y","volume":"25","author":"M Matsuzaki","year":"2011","unstructured":"Matsuzaki M, Hori M, Izumi T, et al. Effects of tolvaptan on volume overload in Japanese patients with heart failure: results of a Phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group Study. Cardiovasc Drugs Ther. 2011;25(Suppl 1):S19\u201331.","journal-title":"Cardiovasc Drugs Ther."},{"key":"121_CR5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1146\/annurev.physiol.65.092101.142638","volume":"65","author":"JM Sands","year":"2003","unstructured":"Sands JM. Mammalian urea transporters. Annu Rev Physiol. 2003;65:543\u201366.","journal-title":"Annu Rev Physiol"},{"key":"121_CR6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/CIRCHEARTFAILURE.112.968230","volume":"6","author":"MA Brisco","year":"2013","unstructured":"Brisco MA, Coca SG, Chen J, et al. Blood urea nitrogen\/creatinine ratio identifies a high-risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure. Circ Heart Fail. 2013;6:233\u20139.","journal-title":"Circ Heart Fail"},{"key":"121_CR7","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1253\/circj.CJ-12-1328","volume":"77","author":"T Imamura","year":"2013","unstructured":"Imamura T, Kinugawa K, Minatsuki S, et al. Urine osmolality estimated using urine urea nitrogen, sodium and creatinine can effectively predict response to tolvaptan in decompensated heart failure patients. Circ J. 2013;77:1208\u201313.","journal-title":"Circ J"},{"key":"121_CR8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1536\/ihj.14-190","volume":"55","author":"E Sato","year":"2014","unstructured":"Sato E, Nakamura T, Amaha M, et al. Effect of tolvaptan in patients with chronic kidney disease due to diabetic nephropathy with heart failure. Int Heart J. 2014;55:533\u20138.","journal-title":"Int Heart J"},{"key":"121_CR9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jacc.2011.01.054","volume":"58","author":"J Lindenfeld","year":"2011","unstructured":"Lindenfeld J, Schrier BW. Blood urea nitrogen. A marker for adverse effects of loop diuretics? J Am Coll Cardiol. 2011;58:383\u20135.","journal-title":"J Am Coll Cardiol"},{"key":"121_CR10","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.CIR.82.5.1724","volume":"82","author":"GS Francis","year":"1990","unstructured":"Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 1990;82:1724\u20139.","journal-title":"Circulation"},{"key":"121_CR11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11897-010-0035-3","volume":"8","author":"G Valania","year":"2011","unstructured":"Valania G, Singh M, Slawsky MT, et al. Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists? Curr Heart Fail Rep. 2011;8:198\u2013205.","journal-title":"Curr Heart Fail Rep"},{"key":"121_CR12","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0022-3565(24)29468-4","volume":"298","author":"RM Edwards","year":"2001","unstructured":"Edwards RM, Brooks DP. Dopamine inhibits vasopressin action in the rat inner medullary collecting duct via alpha(2)-adrenoceptors. J Pharmacol Exp Ther. 2001;298:1001\u20136.","journal-title":"J Pharmacol Exp Ther"},{"key":"121_CR13","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/eurjhf\/hfr150","volume":"13","author":"B Pitt","year":"2011","unstructured":"Pitt B, Gheorghiade M. Vasopressin V1 receptor-mediated aldosterone production as a result of selective V2 receptor antagonism: a potential explanation for the failure of tolvaptan to reduce cardiovascular outcomes in the EVEREST trial. Eur J Heart Fail. 2011;13:1261\u20133.","journal-title":"Eur J Heart Fail."}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-015-0121-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40256-015-0121-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-015-0121-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T19:53:44Z","timestamp":1748375624000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40256-015-0121-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,5]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["121"],"URL":"https:\/\/doi.org\/10.1007\/s40256-015-0121-8","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,5]]}}}